Innospec Inc. (NASDAQ:IOSP) Shares Bought by Segall Bryant & Hamill LLC

Segall Bryant & Hamill LLC lifted its holdings in Innospec Inc. (NASDAQ:IOSP - Free Report) by 18.8% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 100,675 shares of the specialty chemicals company's stock after purchasing an additional 15,925 shares during the quarter. Segall Bryant & Hamill LLC owned about 0.40% of Innospec worth $11,080,000 as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. Blue Trust Inc. grew its position in Innospec by 54.2% during the 4th quarter. Blue Trust Inc. now owns 1,201 shares of the specialty chemicals company's stock worth $136,000 after purchasing an additional 422 shares during the last quarter. KBC Group NV grew its holdings in shares of Innospec by 82.3% during the fourth quarter. KBC Group NV now owns 1,236 shares of the specialty chemicals company's stock valued at $136,000 after buying an additional 558 shares during the last quarter. Smartleaf Asset Management LLC increased its position in shares of Innospec by 91.9% in the 4th quarter. Smartleaf Asset Management LLC now owns 1,802 shares of the specialty chemicals company's stock valued at $198,000 after acquiring an additional 863 shares during the period. PNC Financial Services Group Inc. raised its stake in Innospec by 8.8% in the 4th quarter. PNC Financial Services Group Inc. now owns 1,868 shares of the specialty chemicals company's stock worth $206,000 after acquiring an additional 151 shares during the last quarter. Finally, Point72 Asset Management L.P. acquired a new stake in Innospec during the 3rd quarter worth about $215,000. Hedge funds and other institutional investors own 96.64% of the company's stock.

Remove Ads

Innospec Price Performance

IOSP traded down $2.19 during trading on Friday, reaching $95.20. 123,563 shares of the company's stock were exchanged, compared to its average volume of 139,220. Innospec Inc. has a 1 year low of $94.77 and a 1 year high of $133.71. The company's fifty day simple moving average is $105.47 and its 200-day simple moving average is $110.49. The stock has a market capitalization of $2.38 billion, a P/E ratio of 67.04 and a beta of 1.08.

Innospec (NASDAQ:IOSP - Get Free Report) last posted its earnings results on Tuesday, February 18th. The specialty chemicals company reported $1.41 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.36 by $0.05. The company had revenue of $466.80 million during the quarter, compared to the consensus estimate of $447.43 million. Innospec had a net margin of 1.93% and a return on equity of 12.27%. Equities analysts forecast that Innospec Inc. will post 6.18 EPS for the current year.

Innospec announced that its board has approved a share buyback plan on Monday, March 10th that allows the company to repurchase $50.00 million in shares. This repurchase authorization allows the specialty chemicals company to repurchase up to 2% of its stock through open market purchases. Stock repurchase plans are typically a sign that the company's board of directors believes its shares are undervalued.

Analyst Upgrades and Downgrades

Separately, StockNews.com raised Innospec from a "hold" rating to a "buy" rating in a report on Monday, March 24th.

Insider Transactions at Innospec

In related news, Director Milton C. Blackmore sold 652 shares of the business's stock in a transaction on Friday, February 21st. The shares were sold at an average price of $103.30, for a total value of $67,351.60. Following the completion of the transaction, the director now directly owns 8,376 shares in the company, valued at $865,240.80. The trade was a 7.22 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, SVP Corbin Barnes sold 598 shares of Innospec stock in a transaction on Monday, February 24th. The shares were sold at an average price of $103.06, for a total transaction of $61,629.88. Following the completion of the transaction, the senior vice president now directly owns 8,051 shares of the company's stock, valued at $829,736.06. The trade was a 6.91 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 7,696 shares of company stock worth $794,853 over the last quarter. 1.52% of the stock is currently owned by insiders.

Innospec Company Profile

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.